DelveInsight’s “Knee Osteoarthritis Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the Knee Osteoarthritis pipeline landscapes. 

The report comprises Knee Osteoarthritis pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Knee Osteoarthritis therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Knee Osteoarthritis pipeline products.   

Some of the key takeaways from the Knee Osteoarthritis Pipeline Report:

• Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as Bone Therapeutics, Sun Pharmaceutical, Nordic Bioscience, etc., are developing therapies for the treatment of Knee Osteoarthritis.
• Emerging therapies such as GXCPC1, TA-004 intra-articular injection, and X0002 Spray, are expected to have a significant impact on the Knee Osteoarthritis market in the coming years.  

Knee Osteoarthritis Overview

Knee osteoarthritis (OA), also known as degenerative joint disease, is typically the result of wear and tear and progressive loss of articular cartilage. It is most common in the elderly and can be divided into two types, primary and secondary. Primary osteoarthritis is articular degeneration without any apparent underlying reason. Secondary osteoarthritis is the consequence of either an abnormal concentration of force across the joint as with post-traumatic causes or abnormal articular cartilage, such as rheumatoid arthritis (RA).

Knee osteoarthritis (OA) is closely associated with age, as radiographic evidence of OA occurs in most people by age 65 years and in more than 75% of people older than age 75 years. Although there are many associations and mechanisms that are not well understood, it has been reported that there is a higher prevalence of OA among older women. 

Request a sample for the Pipeline Report: https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight 

Knee Osteoarthritis Pipeline Therapies along with Key Players

Pipeline Therapies:

• GXCPC1
• TA-004 intra-articular injection
• X0002 Spray

Key Companies:

• Bone Therapeutics 
• Jiangsu
• XinChen-Techfields Pharma 
• Nordic
• Bioscience
• Sun
• Pharmaceutical

 Scope of Knee Osteoarthritis Pipeline Drug Insight

• Coverage: Global 
• Major Players: Bone Therapeutics, Sun Pharmaceutical, Nordic Bioscience, and others.
• Pipeline Therapies: GXCPC1, TA-004 intra-articular injection, X0002 Spray, and others.

Table of Contents

Get a customized pipeline report @Knee Osteoarthritis Drugs Pipeline Report  

Related Reports:

Knee Osteoarthritis Market

DelveInsight’s ‘Knee Osteoarthritis-Market Insights, Epidemiology, and Market Forecast—2032’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), 

About DelveInsight

 DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com